Impact of GERD on Daily Life (NIS)

AstraZeneca2,001 enrolled

Overview

The aim of this study is to gather epidemiological data in a population of GERD patients in primary care with a history of erosive esophagitis (less than or equal to 3 years).

Study Type

OBSERVATIONAL

Enrollment

2,001

Conditions

GERD

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with erosive esophagitis (endoscopical findings according to the Los Angeles Classification; grade A-D) currently not treated with a proton pump inhibitor, for whom the general practitioner (GP) has decided to initiate or change the treatment for GERD

Locations (112)

Outcomes

Primary Outcomes

To gather epidemiological data in a population of GERD patients

Time frame: After collection of all questionnaires

Secondary Outcomes

To evaluate the added value of a new patient questionnaire (GERD Impact Scale) as a useful tool for the initial and long-term management of GERD patients: determination of the appropriate treatment and evaluation of the response to treatment.

Time frame: After collection of all questionnaires

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Research Site

Aarschot, Belgium

Research Site

Aartselaar, Belgium

Research Site

Alken, Belgium

Research Site

Angleur, Belgium

Research Site

Antwerp, Belgium

Research Site

Balen, Belgium

Research Site

Berchem, Belgium

Research Site

Beringen, Belgium

Research Site

Beyne-Heusay, Belgium

Research Site

Boechout, Belgium

...and 102 more locations